ID: ALA3976963

Max Phase: Preclinical

Molecular Formula: C16H11BrN2O3

Molecular Weight: 359.18

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1c2n(C)ccc3c-2n(c(=O)c1=O)c1ccc(Br)cc31

Standard InChI:  InChI=1S/C16H11BrN2O3/c1-18-6-5-9-10-7-8(17)3-4-11(10)19-12(9)13(18)15(22-2)14(20)16(19)21/h3-7H,1-2H3

Standard InChI Key:  WHIPNJZITSRCJU-UHFFFAOYSA-N

Associated Targets(non-human)

Meriones unguiculatus 417 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 359.18Molecular Weight (Monoisotopic): 357.9953AlogP: 2.47#Rotatable Bonds: 1
Polar Surface Area: 52.71Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.09CX LogD: 2.09
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.49Np Likeness Score: -0.15

References

1. Sasaki T, Li W, Ohmoto T, Koike K..  (2016)  Evaluation of canthinone alkaloids as cerebral protective agents.,  26  (20): [PMID:27623547] [10.1016/j.bmcl.2016.09.006]

Source